Application of lower doses HMGB1 in vivo (10 to 50 μg/mouse) caused similar symptoms as observed in animals with systemic inflammatory syndrome e.g. after endotoxemia. The gene discussed is HMGB1; the disease is serum lipopolysaccharide activity.